Obesity

The panel released criteria for the emergency use of bamlanivimab in certain populations but has not indicated FDA approval of the treatment.

The FDA has expanded the indication of a previously approved influenza treatment to include post-exposure prophylaxis.

A prescription is no longer needed to obtain the topical lotion for treating head lice. This comes in response to the millions of cases of head lice reported annually by the Centers for Disease Control and...

The FDA has approved the first option for the treatment of adult and pediatric patients aged 12 years or older with COVID-19 who require hospitalization.

Nonsteroidal anti-inflammatory drugs put the fetus at risk for rare but serious kidney complications.

Nonsteroidal anti-inflammatory drugs put the fetus at risk for rare but serious kidney complications.

Nonsteroidal anti-inflammatory drugs put the fetus at risk for rare but serious kidney complications.

The US Food and Drug Administration has approved the use of inmazeb, a combination of monoclonal antibodies, for use as the first treatment for Ebola virus infection.

The FDA has approved a new drug combination for the treatment of adults with malignant pleural mesothelioma.

A Janus kinase inhibitor was approved for the treatment of active polyarticular course juvenile idiopathic arthritis among patients aged 2 years or older.